SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SARS-COV-2 TOTAL (COV2T); SARS-COV-2 IMMUNOASSAY,
|
Back to Search Results |
|
Model Number N/A |
Device Problem
False Positive Result (1227)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/20/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
Qc and calibration was acceptable.Siemens is investigating.The limitations section of the instructions for use states: "this assay should not be used to diagnose or exclude acute infection.Results are not intended to be used as the sole basis for patient management decisions.Test results should be interpreted in conjunction with clinical observations, patient history, epidemiological information, and other laboratory findings.A reactive test result does not exclude past or present infection by other coronaviruses, such as sars-cov-1, mers-cov, hku1, 229e, nl63, or oc43." a false positive/reactive result would not be used in isolation and would be correlated with clinical history.Additional laboratory testing would be used to determine specific antibody presence.Although there is no potential for serious injury in this case, an mdr will be reported to the fda as a requirement of the emergency use authorization (eua).
|
|
Event Description
|
The customer obtained a reactive (positive) atellica im sars-cov-2 total (cov2t) result for a patient sample.The result was considered discordant compared to repeat nonreactive (negative) results from the same sample and from a different sample from the same patient.The customer reported the reactive (positive) result to the physician.There are no known reports of patient intervention or adverse health consequences due to the discordant cov2t result.
|
|
Manufacturer Narrative
|
Mdr 1219913-2020-00643 was filed on december 18, 2020.Additional information -december 22 2020: using atellica im 1300 sars-cov-2 total (cov2t) lot 709001, non-reproducible reactive results observed from multiple replicates from the same sample tube and when compared to another sample tube from the same patient.Sid (b)(6) was recentrifuged 5 days later and processed, resulting in a non-reactive result.Pre-analytic variables can affect the quality of the sample, and deviation from recommended best practices can lead to erroneous results.While there is insufficient information to determine the cause of the non-reproducible reactive result, siemens cannot rule out pre-analytical factors or sample specific issue.Based on the information provided, no product non-conformance identified.Customer is operational.No further action is needed.
|
|
Search Alerts/Recalls
|
|
|